ADVERTISEMENT

NMDC Q3 Review — Margin Expansion Despite Ebitda Miss On Higher Royalty Expense; Systematix Retains 'Hold'

Systematix' target price of Rs 70/share (Rs 80/share earlier), implies an 11% upside from CMP, thereby we maintain Hold rating on the stock.

<div class="paragraphs"><p>NMDC Ltd. reported Q3 FY25 Ebitda of Rs 23.7 billion (+18%/+71% YoY/QoQ), 14% below our estimate due to higher royalty payments during the quarter, in line with higher production.</p><p>(Source: Company website)</p></div>
NMDC Ltd. reported Q3 FY25 Ebitda of Rs 23.7 billion (+18%/+71% YoY/QoQ), 14% below our estimate due to higher royalty payments during the quarter, in line with higher production.

(Source: Company website)

NMDC has also outlined a Rs 700 billion capex plan to reach the 100mt volume target by 2030; finer details of the plan remain to be shared.
To continue reading this story
You must be an existing Premium User
OUR NEWSLETTERS
By signing up you agree to the Terms & Conditions of NDTV Profit